GleamWall
中文EN

CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Hospital & Medical Service Plans · Nasdaq · SEC CIK 1801170 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY54.5%
TTM net income YoY121.3%
TTM EPS YoY119.6%
Revenue 3-yr CAGR14.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin0.5%
Net margin0.5%
FCF margin4.8%
EBITDA margin0.5%

Returns

ROE3.4%
ROA1.9%
ROIC (approx.)7.2%
Asset turnover4.17x

Leverage & solvency

Liabilities / assets48.1%
Debt / equity0.00x
Current ratio1.55x
Interest coverage—

Cash quality & payout

Operating cash flow / net income10.87x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.92B$1.37B
SG&A expense$214.27M$176.48M
Operating income-$85.53M-$45.75M
Interest expense$0$0
Pretax income-$85.55M-$43.01M
Income tax$0$0
Net income-$85.55M-$43.01M
EBITDA-$83.84M-$44.42M
EPS (diluted)——
Weighted avg. shares (diluted)511.97M490.02M
Banking
Deposits$14.60M$14.60M
Balance sheet
Cash & equivalents$78.30M$194.54M
Short-term investments$23.13M$27.00M
Current assets$307.86M$343.12M
PP&E, net$6.38M$5.31M
Total assets$541.01M$580.74M
Current liabilities$208.82M$213.52M
Total liabilities$232.31M$239.60M
Shareholders' equity$308.70M$341.14M
Cash flow statement
Operating cash flow-$66.93M$34.84M
Capital expenditure$2.04M$1.56M
Free cash flow-$68.98M$33.29M
Investing cash flow$4.08M$565,000
Financing cash flow-$53.38M-$17.36M
Depreciation & amortization$1.69M$1.33M
Stock-based compensation$103.66M$114.33M
Share buybacks$18.30M$1.77M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.